Q1Delighted with todays report. Mgmt could be sharper on Analyst questions but I expect that theyve had a ton on top of them over recent weeks in terms of integrations/synergies and cross sell work.
I wont waffle on and on. DOC delivered "exactly" as Doug Taylor of Cannacord and the other 4 Analysts have published. This should give the market confidence now that DOC will hit its targets for the year and as importantly for Investors, its Target Price set by the 5 Analysts ie lowest $3.50/share and AVG is $4.18/share.
Loved Hamza's comments on QoQ 20% growth via APP and that activity isnt episodic but rather, "whole patient engagement" from the first APP use through the patients journey including follow up from DOC staff/nurses etc
GLTA....Solid.